Advertisement
Samsung Biologics acquires GSK's U.S. facility for US$280 mln
World

Samsung Biologics acquires GSK's U.S. facility for US$280 mln

April 1, 2026
Yonhap News Agency
Scroll

SEOUL, April 1 (Yonhap) -- Samsung Biologics, the biotech arm of Samsung Group, ...

Samsung Biologics acquires GSK's U.S. facility for US$280 mln
Read Full Article
Yonhap News Agency
Yonhap News Agency

Coverage and analysis from South Korea. All insights are generated by our AI narrative analysis engine.

South Korea
Bias: lean right
Advertisement
You might also like

Explore More